Home BancShares, Inc. Increases Share Repurchase Program and Announces First Quarter Cash Dividend

(NYSE:HOMB), CONWAY, Ark., Jan. 21, 2025 (GLOBE NEWSWIRE) — Home BancShares, Inc. (NYSE: HOMB) (“Home” or “the Company”), parent company of Centennial Bank (“Centennial”), announced today that its Board of Directors has authorized an increase in the shares available for repurchase and has declared its regular quarterly cash dividend. On January 17, 2025, the Board […]

First Helium Spuds 7-30 Undeveloped Light Oil Well at Worsley

(TSX-V:HELI.V),(OTC US:FHELF),(Other OTC:FHELF),(Boerse Frankfurt – Freiverkehr:2MC), CALGARY, Alberta, Jan. 21, 2025 (GLOBE NEWSWIRE) — First Helium Inc. (“First Helium” or the “Company”) (TSXV: HELI) (OTCQB: FHELF) (FRA: 2MC) today announced that it has begun drilling its proven undeveloped (“PUD”) 7-30 oil location at its Worsley Property in Northern Alberta1,2. Following drilling of the 7-30 vertical

Constellation Software Inc. Announces Annual Interest Rate for Series 1 Debentures

(TSX:CSU), TORONTO, Jan. 21, 2025 (GLOBE NEWSWIRE) — Constellation Software Inc. (TSX: CSU, TSX: CSU.DB) (the “Company“) announced today that the interest rate applicable to the unsecured subordinated floating rate debentures, Series 1 of the Company (the “Debentures“) will be reset to 8.9% per annum on March 31, 2025. This new interest rate is equal

Robex Announces “Best Efforts” Agency Offering

(TSX-V:RBX), NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR DISSEMINATION IN THE U.S. QUÉBEC CITY, Jan. 21, 2025 (GLOBE NEWSWIRE) — Robex Resources Inc. (TSXV: RBX) (“Robex” or the “Company“) is pleased to announce that is has engaged a lead agent to offer for sale to the public, on a “best efforts” agency basis, up

$QTUM, Defiance Quantum Computing ETF, Surpasses $1 Billion in AUM

MIAMI, Jan. 21, 2025 (GLOBE NEWSWIRE) — Defiance ETFs is thrilled to announce that QTUM–Defiance Quantum Computing ETF has reached a major milestone, surpassing $1 billion in assets under management (AUM), a testament to the growing momentum behind quantum computing. QTUM is up over 50% in 2024 (as of 12-31-24). Visit www.defianceetfs.com/qtum/#standardized-performance for standardized performance.

ROSEN, LEADING TRIAL LAWYERS, Encourages Joint Stock Company Kaspi.kz Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm – KSPI

(NASDAQ:KSPI), NEW YORK, Jan. 21, 2025 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Joint Stock Company Kaspi.kz (NASDAQ: KSPI) between January 19, 2024 and September 19, 2024, both dates inclusive (the “Class Period”), of the important February 18, 2025 lead plaintiff deadline in the

CUBI DEADLINE: ROSEN, THE FIRST FILING FIRM, Encourages Customers Bancorp, Inc. Investors to Secure Counsel Before Important January 31 Deadline in Securities Class Action First Filed by the Firm – CUBI

(NYSE:CUBI), NEW YORK, Jan. 21, 2025 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Customers Bancorp, Inc. (NYSE: CUBI) between March 1, 2024 and August 8, 2024, both dates inclusive (the “Class Period”), of the January 31, 2025 lead plaintiff deadline in the securities class

abrdn Emerging Markets Equity Income Fund, Inc. (AEF) Announces Commencement of a Cash Tender Offer

PHILADELPHIA, PA / ACCESS Newswire / January 21, 2025 / abrdn Emerging Markets Equity Income Fund, Inc. (NYSE American:AEF), a non-diversified closed-end fund, announced today the commencement of the previously announced cash tender offer to purchase up to 10,150,355 shares, representing approximately 20% of the Fund’s outstanding shares, at a price per share equal to

ROSEN, A LEADING LAW FIRM, Encourages MGP Ingredients, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – MGPI

(NASDAQ:MGPI), NEW YORK, Jan. 21, 2025 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of MGP Ingredients, Inc. (NASDAQ: MGPI) between May 4, 2023 and October 30, 2024 (the “Class Period”), of the important February 14, 2025 lead plaintiff deadline. SO WHAT: If you purchased

Xilio Therapeutics Announces Initial Phase 2 Data for Vilastobart (XTX101), a Tumor-Activated Anti-CTLA-4, in Combination with Atezolizumab in Patients with Metastatic Microsatellite Stable Colorectal Cancer

(NASDAQ:XLO), 27% preliminary response rate observed in heavily pre-treated microsatellite stable colorectal cancer (MSS CRC) patients without liver metastases Responses were accompanied by decreases in levels of carcinoembryonic antigen (CEA) and circulating tumor DNA (ctDNA) and improvement in clinical symptoms Data continue to demonstrate differentiated safety and tolerability profile for the combination with low incidence

Scroll to Top